Kidney Stone Disease
📧 Sign up to get email alerts when something new happens for Kidney Stone Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: Dietary Oxalate and Innate Immunity in Kidney Stone Disease [NA]
Completed clinical trial examining dietary oxalate and innate immunity in kidney stone disease; results posted.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease [NA]
A clinical trial is evaluating colonization of Oxalobacter formigenes in calcium oxalate nephrolithiasis and is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Comparing Efficacy and Complication Between Prone Versus Prone-Flexed Position for Percutaneous Nephrolithotomy (PCNL) [NA]
A clinical trial update evaluating whether prone or prone-flexed positioning during percutaneous nephrolithotomy affects efficacy and compli…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Antibiotic Selection Using Next Generation Sequencing vs Urine Culture [NA]
Completed clinical trial comparing antibiotic selection using next-generation sequencing versus urine culture for bacterial infections assoc…
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Allopurinol Effect on MDA,NO,KIM-1 Urine Levels, RI and Renal Elastography in Kidney Stone Patients Post ESWL [Phase 4]
Phase 4 clinical trial evaluating the effect of allopurinol on urinary biomarkers and renal parameters after ESWL in kidney stone patients, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-12-16Clinical Trial Update: The Minimal Effective Volume (MEV90) of Ropivacaine 0.75% for Ultrasound-guided Transmuscular Quadratus Lumborum Block [Phase 4]
A Phase 4 trial investigating the minimal effective volume (MEV90) of ropivacaine 0.75% for an ultrasound-guided transmuscular quadratus lum…